tiprankstipranks
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
JSPR
Jasper Therapeutics
RESEARCH TOOLSreports
Want to see JSPR full AI Analyst Report?

Jasper Therapeutics (JSPR) Income Statement

1,055 Followers

Jasper Therapeutics Income Statement

Last quarter (Q4 2025), Jasper Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Jasper Therapeutics's net income was $-9.10M. See Jasper Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.06M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 83.88M$ 76.24M$ 68.86M$ 51.20M$ 36.83M
Depreciation and Amortization
$ 1.06M$ 1.37M$ 1.11M$ 975.00K$ 377.00K
EBITDA
$ -82.83M$ -74.87M$ -67.75M$ -50.22M$ -36.46M
Operating Income
$ -80.52M$ -76.24M$ -68.86M$ -51.20M$ -36.83M
Other Income/Expenses
$ 4.72M$ 4.97M$ 4.40M$ 13.51M$ 6.20M
Pretax Income
$ -75.80M$ -71.27M$ -64.47M$ -37.69M$ -30.64M
Net Income
$ -75.80M$ -71.27M$ -64.47M$ -37.69M$ -30.64M
Per Share Metrics
Basic EPS
$ -3.95$ -4.89$ -6.18$ -10.33$ -26.89
Diluted EPS
$ -3.95$ -4.89$ -6.18$ -10.33$ -26.89
Weighted Average Shares Outstanding
 19.17M 14.58M 10.44M 3.65M 1.14M
Weighted Average Shares Outstanding (Diluted)
 15.33M 14.58M 10.44M 3.65M 1.14M
Currency in USD

Jasper Therapeutics Earnings and Revenue History